PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1876858
PUBLISHER: Frost & Sullivan | PRODUCT CODE: 1876858
Increase in Demand for Biotechnology-derived Ingredients is Driving Transformational Growth due to Advancements in Synthetic Biology and Consumer Preference for Sustainable Ingredients
This Frost & Sullivan report evaluates key trends, dynamics, and growth opportunities in the global personal care active ingredients market from 2022 to 2031. The rising demand for personal care active ingredients is fueled by consumer preferences for natural and sustainable formulations, proven efficacy in addressing specific skin and hair concerns, advancements in biotechnology, and increasing health and wellness awareness.
The market is segmented by type, application, and region. By type, it includes specialty ingredients, organic acids, vitamins, and UV filters, with the specialty ingredients segment anticipated to experience the fastest growth. This is driven by technological advancements in biotechnology and green chemistry, facilitating the development of innovative components, like lab-grown collagen, encapsulated retinol, and bio-fermented hyaluronic acid. In terms of applications, the market includes skin care, hair care, and body care, with skin care representing the largest segment. This growth is attributed to the increasing consumer focus on skin health and a demand for high-performance ingredients that effectively address issues such as acne, aging, pigmentation, sensitivity, and hydration. The report covers 5 regions, namely, North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. Asia-Pacific held the largest revenue share in 2024, experiencing strong growth due to rising disposable incomes, urbanization, heightened awareness of skincare and beauty, a youthful consumer base, and a cultural emphasis on grooming. The region also boasts a robust cosmetics manufacturing sector and a growing adoption of global beauty trends. The report examines the factors driving and restraining this industry and identifies the growth opportunities emerging from the changes in this space for stakeholders and market players to leverage. The base year is 2024, and the forecast period is from 2025 to 2031.
Revenue Forecast
The revenue estimate for the base year 2024 is $3,991.9 million, with a CAGR of 6.2% for the study period of 2022 to 2031.
Scope
Geopolitical Chaos
Why
The current trade tension between China and the United States has resulted in tariffs and regulatory scrutiny on ingredients sourced from China, including vitamins and HA.
The Red Sea conflict and Suez Canal issues have further added to shipping delays and increased freight costs, especially affecting shipments from Asia to Europe and the United States.
Moreover, diverging geopolitical interests are creating a fragmented regulatory landscape, complicating compliance for globally marketed personal care products.
Frost Perspective
Companies must diversify their supplier base across multiple regions to reduce dependency. Building more resilient supply networks through outsourcing, onshoring, or strategic stockpiling helps ensure continuity. Long-term supplier partnerships and investment in local sourcing can also mitigate geopolitical risks.
Leading companies must institutionalize geopolitical risk monitoring and scenario planning, including best practices regarding sustainable development, regulations, and local compliance.
Furthermore, monitoring changes in regulatory requirements and responding proactively to such changes remains vital. A global regulatory foresight is crucial.
Disruptive Technologies
Why
Disruptive technologies in the personal care active ingredients space are transforming how personal care products are formulated, delivered, and personalized.
The emergence of synthetic biology, AI-powered ingredient discovery, and advanced materials science is radically accelerating how active ingredients are developed.
Skin hair and care are moving from mass market to precision personal care, driven by genomics, biomolecular insights, and AI diagnostics.
Additionally, consumers are demanding traceability, ethical sourcing, and reduced environmental impact. Brands that fail to integrate sustainability risk are losing relevance and facing regulatory pushback.
Frost Perspective
Acquisitions and collaborations with biotech companies, AI developers, and formulation platforms will help brands accelerate discovery of next-gen actives (e.g., peptides, smart carriers).
Investing in science-led, sustainable ingredient development, environmental and social governance (ESG) expectations will help brands attain competitive advantage. For example, use of technology-driven personal care ingredients such as nano-emulsions and smart carriers to enhance bioavailability will ensure enhanced efficacy for personal care in novel applications.
Transformative Megatrends
Why
With shifting consumer preferences toward sustainable, equipped, and clinically validated ingredients, the demand for sustainable specialty ingredients is expected to increase. The sustainability trend is projected to drive more companies to adopt sustainable production methods and a new wave of start-ups addressing the needs of consumers for naturally-derived products.
Rather than reversing aging, the market is shifting toward a 'well-aging' philosophy, focusing on long-term skin health, vitality, and radiance. Active ingredients like retinoids, peptides, ceramides, and antioxidants, continue to evolve to meet these needs, often with a greater profile to suit diverse age groups and sensitive skin.
Frost Perspective
Various global players have already transitioned from traditional extraction (e.g., from endangered plants or animals) to biotechnological production of active ingredients, significantly enhancing their sustainability. Companies are increasingly integrating green chemistry and circular economy principles in product design and formulation.
Emerging brands must also ensure that their marketing strategies reflect consumer demand for effective actives (e.g., biomimetic peptides, barrier-enhancing ingredients) in long-term clinical trials to support efficacy claims.
Competitive Environment
Growth Drivers
Growth Restraints